Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study

doi:10.1136/bmjopen-2017-017657

CNU IR > College of Smart Living > Dept. of Childhood Education and Nursery > Periodical Articles > Item 310902800/31606

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/31606

Title:	Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study
Authors:	Yeh, Jun-Jun Wei, Yu-Feng Lin, Cheng-Li Hsu, Wu-Huei
Contributors:	Chia Yi Christian Hosp,Ditmanson Med Fdn, Dept Chest Med Family Med & Geriatr Med Meiho Univ Chia Nan Univ Pharm & Sci Heng Chun Christian Hosp I Shou Univ, E Da Hosp, Dept Internal Med China Med Univ Hosp, Management Off Hlth Data China Med Univ, Coll Med China Med Univ, Coll Med, Grad Inst Clin Med Sci China Med Univ, Coll Med, Sch Med China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med
Keywords:	Systemic Inflammation Beta-Blockers Copd Impact Exacerbations Outcomes Comorbidities Hypertension Carvedilol Mortality
Date:	2017-10
Issue Date:	2018-11-30 15:49:59 (UTC+8)
Publisher:	Bmj Publishing Group
Abstract:	Objectives Patients with asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) and cardiovascular diseases (CVDs) share common risk factors. However, the association between ACOS and the incidence of CVDs has not been reported. This study investigated the relationship between CVDs and ACOS in the general population. Setting Data were obtained from Taiwan's National Health Insurance Research Database for the period 2000 to 2010. Participants The ACOS cohort comprised patients (n= 5814) who had received a diagnosis of asthma and COPD. The non-ACOS cohort comprised patients who had not received a diagnosis of asthma or COPD and were matched to the ACOS cohort (2:1) by age, sex and index date (n= 11 625). Primary and secondary outcome measures The cumulative incidence of CVDs-coronary artery disease (CAD), cardiac dysrhythmia (CD) and heart failure (HF)-was calculated. Cox proportional regression analysis was employed to examine the relationship between ACOS and CVDs. Results After adjustment for multiple confounding factors-age, sex, comorbidities and medications-patients with ACOS were associated with a significantly higher risk of CVDs; the adjusted HRs (aHRs; 95% CI) for CAD, CD and HF were 1.62 (1.50 to 1.76), 1.44 (1.30 to 1.61) and 1.94 (1.73 to 2.19), respectively, whereas those of beta-blockers treatment for CAD, CD and HF were 1.19 (0.92 to 1.53), 0.90 (0.56 to 1.45) and 0.82 (0.49 to 1.38). The aHR of atenolol treatment for CD was 1.72 (1.01 to 2.93). The aHRs (95% CIs) of ACOS without acute exacerbation of COPD (AE-COPD) for CAD, CD and HF were 1.85 (1.70 to 2.01), 1.57 (1.40 to 1.77) and 2.07 (1.82 to 2.35), respectively. Conclusion ACOS was associated with higher CVD risk, even without the presence of previous comorbidities or AE-COPD. No significant differences in CVD events were observed in the ACOS cohort using beta-blockers, except for those using atenolol for treating CD.
Relation:	BMJ Open, v.7, n.10, e017657
Appears in Collections:	[Dept. of Childhood Education and Nursery] Periodical Articles

Files in This Item:

File	Description	Size	Format
bmjopen-2017-017657.pdf		631Kb	Adobe PDF	394	View/Open
index.html		0Kb	HTML	1589	View/Open

Loading...